These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
20-1308307
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
3460 Preston Ridge Road
Alpharetta, Georgia
|
|
30005
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
x
|
|
Accelerated filer
¨
|
|
|
|
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
(Do not check if a smaller reporting company)
|
|
Emerging growth company
¨
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Net sales
|
|
$
|
242.1
|
|
|
$
|
242.1
|
|
|
Cost of products sold
|
|
190.1
|
|
|
183.3
|
|
||
|
Gross profit
|
|
52.0
|
|
|
58.8
|
|
||
|
Selling, general and administrative expenses
|
|
24.9
|
|
|
26.4
|
|
||
|
Integration/restructuring costs
|
|
—
|
|
|
1.1
|
|
||
|
Other expense (income) - net
|
|
0.1
|
|
|
(0.1
|
)
|
||
|
Operating income
|
|
27.0
|
|
|
31.4
|
|
||
|
Interest expense - net
|
|
3.2
|
|
|
2.9
|
|
||
|
Income from continuing operations before income taxes
|
|
23.8
|
|
|
28.5
|
|
||
|
Provision for income taxes
|
|
6.2
|
|
|
9.3
|
|
||
|
Net income
|
|
$
|
17.6
|
|
|
$
|
19.2
|
|
|
|
|
|
|
|
||||
|
Earnings Per Common Share
|
|
|
|
|
|
|
||
|
Basic
|
|
$
|
1.04
|
|
|
$
|
1.13
|
|
|
Diluted
|
|
$
|
1.03
|
|
|
$
|
1.11
|
|
|
|
|
|
|
|
||||
|
Weighted Average Common Shares Outstanding (in thousands)
|
|
|
|
|
|
|
||
|
Basic
|
|
16,779
|
|
|
16,778
|
|
||
|
Diluted
|
|
17,025
|
|
|
17,051
|
|
||
|
|
|
|
|
|
||||
|
Cash Dividends Declared Per Share of Common Stock
|
|
$
|
0.37
|
|
|
$
|
0.33
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Net income
|
|
$
|
17.6
|
|
|
$
|
19.2
|
|
|
Unrealized foreign currency translation gain
|
|
1.7
|
|
|
3.7
|
|
||
|
Reclassification of amortization of adjustments to pension and other postretirement benefit liabilities recognized in net periodic benefit cost (Note 5)
|
|
2.0
|
|
|
1.8
|
|
||
|
Unrealized gain on “available-for-sale” securities
|
|
0.1
|
|
|
—
|
|
||
|
Income from other comprehensive income items
|
|
3.8
|
|
|
5.5
|
|
||
|
Provision for income taxes
|
|
0.8
|
|
|
0.7
|
|
||
|
Other comprehensive income
|
|
3.0
|
|
|
4.8
|
|
||
|
Comprehensive income
|
|
$
|
20.6
|
|
|
$
|
24.0
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
ASSETS
|
|
|
|
|
|
|
||
|
Current Assets
|
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
|
$
|
5.5
|
|
|
$
|
3.1
|
|
|
Accounts receivable (less allowances of $1.6 million and $1.5 million)
|
|
111.5
|
|
|
96.5
|
|
||
|
Inventories
|
|
117.1
|
|
|
116.3
|
|
||
|
Prepaid and other current assets
|
|
18.3
|
|
|
20.4
|
|
||
|
Total Current Assets
|
|
252.4
|
|
|
236.3
|
|
||
|
Property, Plant and Equipment
|
|
|
|
|
|
|
||
|
Property, Plant and Equipment, at cost
|
|
761.6
|
|
|
755.6
|
|
||
|
Less accumulated depreciation
|
|
398.4
|
|
|
391.0
|
|
||
|
Property, plant and equipment—net
|
|
363.2
|
|
|
364.6
|
|
||
|
Deferred Income Taxes
|
|
10.0
|
|
|
6.1
|
|
||
|
Goodwill
|
|
70.8
|
|
|
70.4
|
|
||
|
Intangible Assets—net
|
|
73.4
|
|
|
74.0
|
|
||
|
Other Noncurrent Assets
|
|
17.6
|
|
|
14.2
|
|
||
|
TOTAL ASSETS
|
|
$
|
787.4
|
|
|
$
|
765.6
|
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
||
|
Current Liabilities
|
|
|
|
|
|
|
||
|
Debt payable within one year
|
|
$
|
1.2
|
|
|
$
|
1.2
|
|
|
Accounts payable
|
|
56.4
|
|
|
55.6
|
|
||
|
Accrued expenses
|
|
44.7
|
|
|
51.2
|
|
||
|
Total Current Liabilities
|
|
102.3
|
|
|
108.0
|
|
||
|
Long-term Debt
|
|
225.1
|
|
|
219.7
|
|
||
|
Deferred Income Taxes
|
|
18.3
|
|
|
10.1
|
|
||
|
Noncurrent Employee Benefits
|
|
87.0
|
|
|
86.7
|
|
||
|
Other Noncurrent Obligations
|
|
6.2
|
|
|
2.8
|
|
||
|
TOTAL LIABILITIES
|
|
438.9
|
|
|
427.3
|
|
||
|
Contingencies and Legal Matters (
Note 8
)
|
|
—
|
|
|
—
|
|
||
|
TOTAL STOCKHOLDERS’ EQUITY
|
|
348.5
|
|
|
338.3
|
|
||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
$
|
787.4
|
|
|
$
|
765.6
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
OPERATING ACTIVITIES
|
|
|
|
|
|
|
||
|
Net income
|
|
$
|
17.6
|
|
|
$
|
19.2
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
||
|
Depreciation and amortization
|
|
7.8
|
|
|
8.2
|
|
||
|
Stock-based compensation
|
|
2.5
|
|
|
2.5
|
|
||
|
Deferred income tax provision
|
|
3.3
|
|
|
3.5
|
|
||
|
Increase in working capital
|
|
(11.3
|
)
|
|
(18.8
|
)
|
||
|
Pension and other postretirement benefits
|
|
1.9
|
|
|
1.7
|
|
||
|
Other
|
|
0.2
|
|
|
(0.2
|
)
|
||
|
NET CASH PROVIDED BY OPERATING ACTIVITIES
|
|
22.0
|
|
|
16.1
|
|
||
|
|
|
|
|
|
||||
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
||
|
Capital expenditures
|
|
(11.5
|
)
|
|
(11.3
|
)
|
||
|
Other
|
|
(0.2
|
)
|
|
(0.4
|
)
|
||
|
NET CASH USED IN INVESTING ACTIVITIES
|
|
(11.7
|
)
|
|
(11.7
|
)
|
||
|
|
|
|
|
|
||||
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
||
|
Long-term borrowings (Note 4)
|
|
81.8
|
|
|
89.1
|
|
||
|
Repayments of long-term debt (Note 4)
|
|
(76.9
|
)
|
|
(81.8
|
)
|
||
|
Cash dividends paid
|
|
(6.3
|
)
|
|
(5.6
|
)
|
||
|
Shares purchased (Note 7)
|
|
(6.8
|
)
|
|
(5.3
|
)
|
||
|
Proceeds from exercise of stock options
|
|
0.3
|
|
|
0.1
|
|
||
|
NET CASH USED IN FINANCING ACTIVITIES
|
|
(7.9
|
)
|
|
(3.5
|
)
|
||
|
|
|
|
|
|
||||
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
|
|
—
|
|
|
—
|
|
||
|
NET INCREASE IN CASH AND CASH EQUIVALENTS
|
|
2.4
|
|
|
0.9
|
|
||
|
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR
|
|
3.1
|
|
|
4.2
|
|
||
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
|
$
|
5.5
|
|
|
$
|
5.1
|
|
|
|
|
|
|
|
||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
|
|
|
|
|
|
||
|
Cash paid during period for interest, net of interest expense capitalized
|
|
$
|
0.6
|
|
|
$
|
0.2
|
|
|
Cash paid during period for income taxes
|
|
$
|
1.7
|
|
|
$
|
5.3
|
|
|
Non-cash investing activities:
|
|
|
|
|
|
|
||
|
Liability for equipment acquired
|
|
$
|
3.5
|
|
|
$
|
5.5
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Income from continuing operations
|
|
$
|
17.6
|
|
|
$
|
19.2
|
|
|
Amounts attributable to participating securities
|
|
(0.1
|
)
|
|
(0.2
|
)
|
||
|
Net income available to common stockholders
|
|
$
|
17.5
|
|
|
$
|
19.0
|
|
|
|
|
|
|
|
||||
|
Weighted-average basic shares outstanding
|
|
16,779
|
|
|
16,778
|
|
||
|
|
|
|
|
|
|
|
||
|
Basic earnings per share
|
|
$
|
1.04
|
|
|
$
|
1.13
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Income from continuing operations
|
|
$
|
17.6
|
|
|
$
|
19.2
|
|
|
Amounts attributable to participating securities
|
|
(0.1
|
)
|
|
(0.2
|
)
|
||
|
Net income available to common stockholders
|
|
$
|
17.5
|
|
|
$
|
19.0
|
|
|
|
|
|
|
|
||||
|
Weighted-average basic shares outstanding
|
|
16,779
|
|
|
16,778
|
|
||
|
Add: Assumed incremental shares under stock compensation plans (a)
|
|
246
|
|
|
273
|
|
||
|
Weighted-average diluted shares
|
|
17,025
|
|
|
17,051
|
|
||
|
|
|
|
|
|
|
|
||
|
Diluted earnings per share
|
|
$
|
1.03
|
|
|
$
|
1.11
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
|
|
|
Carrying
Value
|
|
Fair Value (a)(b)
|
|
Carrying
Value
|
|
Fair Value (a)(b)
|
||||||||
|
2021 Senior Notes (5.25% fixed rate)
|
|
$
|
175.0
|
|
|
$
|
169.6
|
|
|
$
|
175.0
|
|
|
$
|
169.5
|
|
|
Global Revolving Credit Facilities (variable rates)
|
|
48.3
|
|
|
48.3
|
|
|
42.9
|
|
|
42.9
|
|
||||
|
German loan agreement (2.45% fixed rate)
|
|
6.6
|
|
|
6.6
|
|
|
6.8
|
|
|
6.8
|
|
||||
|
Total debt
|
|
$
|
229.9
|
|
|
$
|
224.5
|
|
|
$
|
224.7
|
|
|
$
|
219.2
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Raw materials
|
|
$
|
32.1
|
|
|
$
|
31.6
|
|
|
Work in progress
|
|
30.7
|
|
|
26.8
|
|
||
|
Finished goods
|
|
59.3
|
|
|
63.0
|
|
||
|
Supplies and other
|
|
3.2
|
|
|
3.1
|
|
||
|
|
|
125.3
|
|
|
124.5
|
|
||
|
Adjust FIFO inventories to LIFO cost
|
|
(8.2
|
)
|
|
(8.2
|
)
|
||
|
Total
|
|
$
|
117.1
|
|
|
$
|
116.3
|
|
|
|
|
Net unrealized foreign
currency translation
gain (loss)
|
|
Net gain (loss) from
pension and other
postretirement
liabilities
|
|
Unrealized gain (loss) on
“available-for-sale”
securities
|
|
Accumulated other
comprehensive income
(loss)
|
||||||||
|
AOCI — December 31, 2016
|
|
$
|
(27.4
|
)
|
|
$
|
(64.5
|
)
|
|
$
|
(0.1
|
)
|
|
$
|
(92.0
|
)
|
|
Other comprehensive income before reclassifications
|
|
1.7
|
|
|
—
|
|
|
0.1
|
|
|
1.8
|
|
||||
|
Amounts reclassified from AOCI
|
|
—
|
|
|
2.0
|
|
|
—
|
|
|
2.0
|
|
||||
|
Income from other comprehensive income items
|
|
1.7
|
|
|
2.0
|
|
|
0.1
|
|
|
3.8
|
|
||||
|
Provision for income taxes
|
|
0.1
|
|
|
0.7
|
|
|
—
|
|
|
0.8
|
|
||||
|
Other comprehensive income
|
|
1.6
|
|
|
1.3
|
|
|
0.1
|
|
|
3.0
|
|
||||
|
AOCI — March 31, 2017
|
|
$
|
(25.8
|
)
|
|
$
|
(63.2
|
)
|
|
$
|
—
|
|
|
$
|
(89.0
|
)
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
2021 Senior Notes (5.25% fixed rate) due May 2021
|
|
$
|
175.0
|
|
|
$
|
175.0
|
|
|
Global Revolving Credit Facilities (variable rates) due December 2019
|
|
48.3
|
|
|
42.9
|
|
||
|
German loan agreement (2.45% fixed rate) due in 32 equal quarterly installments ending September 2022
|
|
6.6
|
|
|
6.8
|
|
||
|
Deferred financing costs
|
|
(3.6
|
)
|
|
(3.8
|
)
|
||
|
Total debt
|
|
226.3
|
|
|
220.9
|
|
||
|
Less: Debt payable within one year
|
|
1.2
|
|
|
1.2
|
|
||
|
Long-term debt
|
|
$
|
225.1
|
|
|
$
|
219.7
|
|
|
|
|
Pension Benefits
|
|
Postretirement Benefits
Other than Pensions
|
||||||||||||
|
|
|
Three Months Ended March 31,
|
||||||||||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Service cost
|
|
$
|
1.3
|
|
|
$
|
1.2
|
|
|
$
|
0.3
|
|
|
$
|
0.3
|
|
|
Interest cost
|
|
3.7
|
|
|
4.0
|
|
|
0.4
|
|
|
0.4
|
|
||||
|
Expected return on plan assets (a)
|
|
(4.8
|
)
|
|
(4.7
|
)
|
|
—
|
|
|
—
|
|
||||
|
Recognized net actuarial loss
|
|
1.9
|
|
|
1.7
|
|
|
—
|
|
|
0.1
|
|
||||
|
Amortization of prior service benefit
|
|
0.1
|
|
|
—
|
|
|
—
|
|
|
(0.1
|
)
|
||||
|
Net periodic benefit cost
|
|
$
|
2.2
|
|
|
$
|
2.2
|
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted
|
143,726
|
|
|
|
Per share weighted average exercise price
|
$
|
82.11
|
|
|
Per share weighted average grant date fair value
|
$
|
13.54
|
|
|
Expected term in years
|
5.7
|
|
|
Risk free interest rate
|
2.1
|
%
|
|
Volatility
|
22.9
|
%
|
|
Dividend yield
|
3.0
|
%
|
|
Options vested
|
92,107
|
|
|
|
Aggregate grant date fair value of Options vested (in millions)
|
$
|
1.4
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Options outstanding
|
|
534,885
|
|
|
530,462
|
|
||
|
Aggregate intrinsic value (in millions)
|
|
$
|
12.4
|
|
|
$
|
25.0
|
|
|
Per share weighted average exercise price
|
|
$
|
53.51
|
|
|
$
|
38.35
|
|
|
Exercisable Options
|
|
289,140
|
|
|
336,336
|
|
||
|
Aggregate intrinsic value (in millions)
|
|
$
|
10.7
|
|
|
$
|
19.3
|
|
|
Unvested Options
|
|
245,745
|
|
|
194,126
|
|
||
|
Per share weighted average grant date fair value
|
|
$
|
14.31
|
|
|
$
|
15.15
|
|
|
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
|
2017
|
|
2016
|
||||||||||
|
|
|
Shares
|
|
$
|
|
Shares
|
|
$
|
||||||
|
2016 Stock Purchase Plan
|
|
85,354
|
|
|
$
|
6.8
|
|
|
—
|
|
|
$
|
—
|
|
|
2015 Stock Purchase Plan
|
|
—
|
|
|
—
|
|
|
93,600
|
|
|
5.2
|
|
||
|
Contract Expiration
Date
|
Location
|
Union
|
Number of
Employees
|
|
|
June 2017
|
Neenah Germany
|
IG BCE
|
(a)
|
|
|
January 2018
|
Whiting, WI (b)
|
USW
|
196
|
|
|
June 2018
|
Neenah, WI (b)
|
USW
|
267
|
|
|
July 2018
|
Munising, MI (b)
|
USW
|
199
|
|
|
May 2019
|
Appleton, WI (b)
|
USW
|
74
|
|
|
August 2021
|
Brattleboro, VT
|
USW
|
70
|
|
|
November 2021
|
Lowville, NY
|
USW
|
104
|
|
|
•
|
The Technical Products segment is an aggregation of the Company’s filtration and performance materials businesses which are similar in terms of economic characteristics, nature of products, processes, customer class and product distribution methods and is an international producer of fiber-formed, coated and/or saturated specialized media that delivers high performance benefits to customers. Included in this segment are filtration media, tape and abrasives backings products, and durable label and specialty substrate products.
|
|
•
|
The Fine Paper and Packaging business is a leading supplier of premium printing and other high-end specialty papers, premium packaging and specialty office papers primarily in North America.
|
|
•
|
The Other segment is composed of papers sold to converters for end uses such as covering materials for datebooks, diaries, yearbooks and traditional photo albums. These product lines represent an operating segment which does not meet the quantitative threshold for a reportable segment, however, due to the dissimilar nature of these products, they are not managed as part of either the Fine Paper and Packaging or Technical Products businesses.
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Net sales
|
|
|
|
|
|
|
||
|
Technical Products
|
|
$
|
121.9
|
|
|
$
|
121.5
|
|
|
Fine Paper and Packaging
|
|
114.3
|
|
|
113.8
|
|
||
|
Other
|
|
5.9
|
|
|
6.8
|
|
||
|
Consolidated
|
|
$
|
242.1
|
|
|
$
|
242.1
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Operating income (loss)
|
|
|
|
|
|
|
||
|
Technical Products
|
|
$
|
12.5
|
|
|
$
|
19.2
|
|
|
Fine Paper and Packaging
|
|
20.3
|
|
|
17.5
|
|
||
|
Other
|
|
(0.3
|
)
|
|
—
|
|
||
|
Unallocated corporate costs
|
|
(5.5
|
)
|
|
(5.3
|
)
|
||
|
Consolidated
|
|
$
|
27.0
|
|
|
$
|
31.4
|
|
|
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
|
2017
|
|
2016
|
||||||||||
|
Net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Technical Products
|
|
$
|
121.9
|
|
|
51
|
%
|
|
$
|
121.5
|
|
|
50
|
%
|
|
Fine Paper and Packaging
|
|
114.3
|
|
|
47
|
%
|
|
113.8
|
|
|
47
|
%
|
||
|
Other
|
|
5.9
|
|
|
2
|
%
|
|
6.8
|
|
|
3
|
%
|
||
|
Consolidated
|
|
$
|
242.1
|
|
|
100
|
%
|
|
$
|
242.1
|
|
|
100
|
%
|
|
|
|
Three Months Ended March 31,
|
|
Change in Net Sales Compared to Prior Period
|
||||||||||||||||||||
|
|
|
|
|
|
Change Due To
|
|||||||||||||||||||
|
|
|
2017
|
|
2016
|
|
Total Change
|
|
Volume
|
|
Net Price
|
|
Currency
|
||||||||||||
|
Technical Products
|
|
$
|
121.9
|
|
|
$
|
121.5
|
|
|
$
|
0.4
|
|
|
$
|
0.8
|
|
|
$
|
2.0
|
|
|
$
|
(2.4
|
)
|
|
Fine Paper and Packaging
|
|
114.3
|
|
|
113.8
|
|
|
$
|
0.5
|
|
|
4.9
|
|
|
(4.4
|
)
|
|
—
|
|
|||||
|
Other
|
|
5.9
|
|
|
6.8
|
|
|
$
|
(0.9
|
)
|
|
(0.9
|
)
|
|
—
|
|
|
—
|
|
|||||
|
Consolidated
|
|
$
|
242.1
|
|
|
$
|
242.1
|
|
|
$
|
—
|
|
|
$
|
4.8
|
|
|
$
|
(2.4
|
)
|
|
$
|
(2.4
|
)
|
|
•
|
Net sales in our technical products business increased
$0.4 million
from the prior period due to organic volume growth
led by backings, labels, and transportation filtration, and a higher average selling price due to a higher value sales mix. These items were mostly offset by unfavorable currency exchange effects.
|
|
•
|
Net sales in our fine paper and packaging business increased
$0.5 million
from the prior year period due to
higher volumes and increased selling prices that were largely offset by a lower priced mix due to a higher proportion of sales of non-branded products.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||
|
|
|
2017
|
|
2016
|
||
|
Net sales
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of products sold
|
|
78.5
|
%
|
|
75.7
|
%
|
|
Gross profit
|
|
21.5
|
%
|
|
24.3
|
%
|
|
Selling, general and administrative expenses
|
|
10.3
|
%
|
|
10.9
|
%
|
|
Integration/restructuring costs
|
|
—
|
%
|
|
0.4
|
%
|
|
Other expense (income) - net
|
|
—
|
%
|
|
—
|
%
|
|
Operating income
|
|
11.2
|
%
|
|
13.0
|
%
|
|
Interest expense - net
|
|
1.4
|
%
|
|
1.2
|
%
|
|
Income from continuing operations before income taxes
|
|
9.8
|
%
|
|
11.8
|
%
|
|
Provision for income taxes
|
|
2.5
|
%
|
|
3.9
|
%
|
|
Income from continuing operations
|
|
7.3
|
%
|
|
7.9
|
%
|
|
|
|
|
|
|
|
Change in Operating Income Compared to Prior Period
|
||||||||||||||||||||||||||
|
|
|
Three Months Ended March 31,
|
|
|
|
Change Due To
|
||||||||||||||||||||||||||
|
|
|
|
Total
|
|
|
|
Net
|
|
Input
|
|
|
|
|
|||||||||||||||||||
|
|
|
2017
|
|
2016
|
|
Change
|
|
Volume
|
|
Price (a)
|
|
Costs (b)
|
|
Currency
|
|
Other (c)
|
||||||||||||||||
|
Technical Products
|
|
$
|
12.5
|
|
|
$
|
19.2
|
|
|
$
|
(6.7
|
)
|
|
$
|
0.5
|
|
|
$
|
0.2
|
|
|
$
|
(0.5
|
)
|
|
$
|
(0.5
|
)
|
|
$
|
(6.4
|
)
|
|
Fine Paper and Packaging
|
|
20.3
|
|
|
17.5
|
|
|
2.8
|
|
|
1.5
|
|
|
(2.3
|
)
|
|
0.7
|
|
|
—
|
|
|
2.9
|
|
||||||||
|
Other
|
|
(0.3
|
)
|
|
—
|
|
|
(0.3
|
)
|
|
(0.6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.3
|
|
||||||||
|
Unallocated corporate costs
|
|
(5.5
|
)
|
|
(5.3
|
)
|
|
(0.2
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.2
|
)
|
||||||||
|
Consolidated
|
|
$
|
27.0
|
|
|
$
|
31.4
|
|
|
$
|
(4.4
|
)
|
|
$
|
1.4
|
|
|
$
|
(2.1
|
)
|
|
$
|
0.2
|
|
|
$
|
(0.5
|
)
|
|
$
|
(3.4
|
)
|
|
•
|
Operating income for our technical products business decreased
$6.7 million
from the prior year period primarily due to higher
manufacturing costs, including $3.1 million resulting from the U.S. filtration capacity start-up, approximately $2 million of higher filtration costs for downtime and other costs in Germany, and other unfavorable impacts from higher material costs and currency effects. These items were partially offset by benefits from higher sales volumes and lower integration and restructuring costs.
Excluding integration and restructuring costs of
$0.3 million
for 2016, operating income decreased
$7.0 million
from the prior year.
|
|
•
|
Operating income for our fine paper and packaging business increased
$2.8 million
from the prior year period as a result of
reduced SG&A expense, higher volumes and selling prices, and lower input and integration costs, that were partially offset by a lower priced product mix.
Excluding integration costs of
$0.3 million
for 2016, operating income increased
$2.5 million
.
|
|
•
|
Unallocated corporate expenses for the three months ended
March 31, 2017
of
$5.5 million
was
$0.2 million
higher than the prior year period. The unfavorable comparison to the prior year period is primarily due to timing of certain expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Operating income
|
|
|
|
|
|
|
||
|
Technical Products
|
|
$
|
12.5
|
|
|
$
|
19.2
|
|
|
Fine Paper and Packaging
|
|
20.3
|
|
|
17.5
|
|
||
|
Other
|
|
(0.3
|
)
|
|
—
|
|
||
|
Unallocated corporate costs
|
|
(5.5
|
)
|
|
(5.3
|
)
|
||
|
Operating Income as Reported
|
|
$
|
27.0
|
|
|
$
|
31.4
|
|
|
Adjustments to Reported Operating Income
|
|
|
|
|
|
|
||
|
Technical Products
|
|
|
|
|
|
|
||
|
Integration/Restructuring costs
|
|
—
|
|
|
0.3
|
|
||
|
Fine Paper and Packaging
|
|
|
|
|
|
|
||
|
Integration costs
|
|
—
|
|
|
0.3
|
|
||
|
Other
|
|
|
|
|
|
|||
|
Integration costs
|
|
—
|
|
|
0.2
|
|
||
|
Unallocated corporate costs
|
|
|
|
|
|
|
||
|
Restructuring costs
|
|
—
|
|
|
0.3
|
|
||
|
Total Adjustments to Reported Operating Income
|
|
—
|
|
|
1.1
|
|
||
|
Operating Income as Adjusted
|
|
$
|
27.0
|
|
|
$
|
32.5
|
|
|
•
|
SG&A expense of
$24.9 million
for the three months ended
March 31, 2017
was
$1.5 million
lower than SG&A expense of
$26.4 million
in the prior year period due to timing of certain items. For the three months ended
March 31, 2017
, SG&A expense as a percent of sales decreased to
10.3
percent from
10.9
percent in the prior year period.
|
|
•
|
For the three months ended
March 31, 2017
, we incurred net interest expense of
$3.2 million
which was higher than the
$2.9 million
for prior year period, primarily due to capitalization of interest of $0.2 million for the U.S. filtration project in 2016.
|
|
•
|
In general, our effective tax rate differs from the U.S. statutory tax rate of 35 percent primarily due to the proportion of pre-tax income in jurisdictions with marginal tax rates that differ from the U.S. statutory tax rate, research and development and other tax credits and excess tax benefits from stock compensation. For the three months ended
March 31, 2017
and
2016
, we recorded an income tax provision of
$6.2 million
and
$9.3 million
, respectively. The effective income tax rate of
26 percent
for the three months ended
March 31, 2017
was lower than the tax rate of
33 percent
for the three months ended March 31, 2016. The 2017 rate was lower primarily due to excess tax benefits which reduced the income tax expense.
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Net cash flow provided by (used in):
|
|
|
|
|
|
|
||
|
Operating activities
|
|
$
|
22.0
|
|
|
$
|
16.1
|
|
|
|
|
|
|
|
||||
|
Investing activities:
|
|
|
|
|
|
|
||
|
Capital expenditures
|
|
(11.5
|
)
|
|
(11.3
|
)
|
||
|
Other investing activities
|
|
(0.2
|
)
|
|
(0.4
|
)
|
||
|
Total
|
|
(11.7
|
)
|
|
(11.7
|
)
|
||
|
|
|
|
|
|
||||
|
Financing activities:
|
|
|
|
|
||||
|
Net borrowings of long-term debt
|
|
4.9
|
|
|
7.3
|
|
||
|
Other financing activities
|
|
(12.8
|
)
|
|
(10.8
|
)
|
||
|
Total
|
|
(7.9
|
)
|
|
(3.5
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
||
|
Net increase in cash and cash equivalents
|
|
$
|
2.4
|
|
|
$
|
0.9
|
|
|
•
|
Cash provided by operating activities of
$22.0 million
for the
three
months ended
March 31, 2017
was
$5.9 million
higher than cash provided by operating activities of
$16.1 million
in the prior year period. The favorable comparison was
primarily due to a decrease in our investment in working capital, partly offset by lower operating earnings.
|
|
•
|
For both of the
three
months ended
March 31, 2017
and
2016
, cash used by investing activities was
$11.7 million
, primarily consisting of capital expenditures. For the full year
2017
, we expect aggregate annual capital expenditures in our normal range of approximately 3 to 5 percent of net sales.
|
|
•
|
For the
three
months ended
March 31, 2017
and
2016
, cash used in financing activities was
$7.9 million
and
$3.5 million
, respectively. Cash used in financing activities consists primarily of dividends paid and share repurchases, offset by net borrowings of long-term debt. For the
three
months ended March 31, 2017 and 2016, we drew down from our Global Revolving Credit Facilities for daily cash management activities.
|
|
•
|
Availability under our revolving credit facility varies over time depending on the value of our inventory, receivables and various capital assets. As of
March 31, 2017
, we had
$48.3 million
outstanding under our Global Revolving Credit Facilities and
$120.8 million
of available credit (based on exchange rates at
March 31, 2017
).
|
|
•
|
We have required debt principal payments through
March 31,
2018
of
$1.2 million
for principal payments on the German loan agreement.
|
|
•
|
For the
three
months ended
March 31, 2017
, cash and cash equivalents increased
$2.4 million
to
$5.5 million
at
March 31, 2017
from
$3.1 million
at
December 31, 2016
. Total debt increased
$5.4 million
to
$226.3 million
at
March 31, 2017
from
$220.9 million
at
December 31, 2016
. Net debt (total debt minus cash and cash equivalents) increased by
$3.0 million
.
|
|
•
|
As of
March 31, 2017
, our cash balance of
$5.5 million
consists of $2.2 million in the U.S. and $3.3 million held at entities outside of the U.S. As of
March 31, 2017
, there were no restrictions regarding the repatriation of our non-U.S. cash and, we believe, the repatriation of these cash balances to the U.S. would not materially increase our income tax provision.
|
|
•
|
In November 2016, our Board of Directors approved a twelve percent increase in the annual dividend rate on our common stock to
$1.48
per share. Beginning in March 2017, the dividend is being paid in four equal quarterly installments of
$0.37
per share. For the
three
months ended
March 31, 2017
and
2016
, we paid cash dividends of
$0.37
per common share or
$6.3 million
and
0.33
per common share or
$5.6 million
, respectively.
|
|
•
|
Purchases under the 2016 Stock Purchase Plan will be made from time to time in the open market or in privately negotiated transactions in accordance with the requirements of applicable law. The timing and amount of any purchases will depend on share price, market conditions and other factors. The 2016 Stock Purchase Plan does not require us to purchase any specific number of shares and may be suspended or discontinued at any time. For the
three
months ended
March 31, 2017
and
2016
, we repurchased approximately 85,400 shares of Common Stock at a cost of
$6.8 million
and 93,600 shares of Common Stock at a cost of $5.2 million, respectively. For further details on our Stock Purchase Plans refer to Note 7.
|
|
•
|
As of
March 31, 2017
, we had $24.8 million of U.S. federal and state research and development ("R&D") Credits which, if not used, will expire between 2029 and 2037 for the U.S. federal R&D Credits and between 2017 and 2032 for the state R&D Credits. We reflected a valuation allowance of $3.1 million against a portion of the R&D Credits. In addition, as of
March 31, 2017
, we had $46.6 million of state net operating losses ("NOLs"). Our state NOLs may be used to offset approximately $2.2 million in state income taxes. If not used, substantially all of the state NOLs will expire in various amounts between 2017 and 2037.
|
|
•
|
changes in market demand for our products due to global economic conditions;
|
|
•
|
the impact of competition, both domestic and international, changes in industry production capacity, including the construction of new mills or new machines, the closing of mills and incremental changes due to capital expenditures or productivity increases;
|
|
•
|
the enactment of adverse state, federal or foreign tax or other legislation or changes in government policy or regulation;
|
|
•
|
fluctuations in (i) exchange rates (in particular changes in the U.S. dollar/Euro currency exchange rates) and (ii) interest rates;
|
|
•
|
increases in commodity prices, (particularly for pulp, energy and latex) due to constrained global supplies or unexpected supply disruptions;
|
|
•
|
the availability of raw materials and energy;
|
|
•
|
strikes, labor stoppages and changes in our collective bargaining agreements and relations with our employees and unions;
|
|
•
|
capital and credit market volatility and fluctuations in global equity and fixed-income markets;
|
|
•
|
unanticipated expenditures related to the cost of compliance with environmental and other governmental regulations;
|
|
•
|
our ability to control costs and implement measures designed to enhance operating efficiencies;
|
|
•
|
the loss of current customers or the inability to obtain new customers;
|
|
•
|
loss of key personnel;
|
|
•
|
increases in the funding requirements for our pension and postretirement liabilities;
|
|
•
|
changes in asset valuations including write-downs of assets including property, plant and equipment, inventory, accounts receivable, deferred tax assets or other assets for impairment or other reasons;
|
|
•
|
our existing and future indebtedness;
|
|
•
|
our ability to successfully integrate acquired businesses into our existing operations;
|
|
•
|
our net operating losses may not be available to offset our tax liability and other tax planning strategies may not be effective; and
|
|
•
|
other risks that are detailed from time to time in reports we file with the SEC.
|
|
Months in 2017
|
|
Total Number of
Shares Purchased
|
|
Average Price Paid
Per Share
|
|
Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
|
|
Approximate Dollar
Value of Shares that May
Yet Be Purchased Under
Publicly Announced
Plans or Programs (a)
|
||||||
|
January
|
|
28,414
|
|
|
$
|
83.11
|
|
|
28,414
|
|
|
$
|
15,230,343
|
|
|
February
|
|
57,485
|
|
|
$
|
77.38
|
|
|
56,940
|
|
|
$
|
10,824,468
|
|
|
March
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
10,824,468
|
|
|
Exhibit
Number
|
|
Exhibit
|
|
|
|
|
|
|
|
31.1
|
|
|
Certification of the CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
31.2
|
|
|
Certification of the CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
32.1
|
|
|
Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
32.2
|
|
|
Certification of CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
101.INS
|
|
|
XBRL Instance Document (filed herewith).
|
|
|
|
|
|
|
101.SCH
|
|
|
XBRL Taxonomy Extension Schema Document (filed herewith).
|
|
|
|
|
|
|
101.CAL
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).
|
|
|
|
|
|
|
101.DEF
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).
|
|
|
|
|
|
|
101.LAB
|
|
|
XBRL Taxonomy Extension Label Linkbase Document (filed herewith).
|
|
|
|
|
|
|
101.PRE
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).
|
|
|
|
NEENAH PAPER, INC
|
|
|
|
|
|
|
By:
|
/s/ John P. O'Donnell
|
|
|
|
John P. O’Donnell
|
|
|
|
President, Chief Executive Officer and Director
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ Bonnie C. Lind
|
|
|
|
Bonnie C. Lind
|
|
|
|
Senior Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
|
|
|
|
|
|
|
|
/s/ Larry N. Brownlee
|
|
|
|
Larry N. Brownlee
|
|
|
|
Vice President — Controller (Principal Accounting Officer)
|
|
|
|
|
|
May 10, 2017
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Vulcan Materials Company | VMC |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|